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seudorabies virus, an 
 
 
 
-herpesvirus, is capable of in-
fecting the nervous system and spreading between
synaptically connected neurons in diverse hosts. At
least three viral membrane proteins (gE, gI, and Us9) are
necessary for the spread of infection from presynaptic to
postsynaptic neurons (anterograde spread) in infected ro-
dents. To understand how these proteins effect anterograde
spread between neurons, we analyzed the subcellular lo-
calization of viral proteins after infection of cultured rat
sympathetic neurons with wild-type or mutant viruses. Af-
ter Us9-null mutant infections but not gE-null mutant infec-
tions, only a subset of the viral structural proteins had en-
P
 
tered axons. Surprisingly, capsid and tegument proteins but
not viral membrane proteins were detected in axons. The
spread of Us9 missense mutants in the rodent nervous sys-
tem correlated with the amount of viral membrane proteins
localized to axons. We conclude that the Us9 membrane
protein controls axonal localization of diverse viral mem-
brane proteins but not that of capsid or tegument proteins.
The data support a model where virion subassemblies but
not complete virions are transported in the axon. Our re-
sults provide new insight into the process of virion assem-
bly and exit from neurons that leads to directional spread
of herpesviruses in the nervous system.
 
Introduction
 
 
 
-Herpesviruses are unique parasites of the vertebrate pe-
ripheral nervous system (PNS)*. After primary infection at
an epithelial surface, virus invades the termini of sensory and
autonomic neurons innervating the infected tissue. Subse-
quently, virion components are transported through axons to
the cell bodies of these neurons, usually a substantial distance
from the termini. Movement of virion components from the
axon terminal to the cell body is thought to occur via micro-
tubule-based motors such as dynein moving material in a
plus-to-minus direction (Enquist et al., 1998; Bearer et al.,
1999, 2000; Sodeik, 2000). Within a week of invading the
cell bodies of PNS ganglionic neurons, production of infec-
tious virus ceases, and a quiescent or latent state is estab-
lished. Months or years later, the latent infection can be reac-
tivated, and new virions are produced in PNS ganglionic
neurons. The virions then travel via axons to the periphery
and infect the epithelia, producing infectious virus that can
spread to other hosts. Long distance movement of newly rep-
licated virions from the cell body to distant axon terminals is
not well understood but has been suggested to occur using
microtubule-based motors such as the kinesins that move
cargo in the minus-to-plus direction (Enquist et al., 1998;
Sodeik, 2000; Smith et al., 2001). The movement of virions
in PNS axons toward the cell body after primary infection or
away from the neuronal cell body via PNS axons after repli-
cation implies that 
 
 
 
-herpesviruses may encode gene prod-
ucts capable of regulating directional axonal transport.
Evidence of viral proteins capable of affecting direction of
virus movement in living animals came from studies of cir-
cuit-specific transneuronal infection by pseudorabies virus
(PRV; a broad host range 
 
 
 
-herpesvirus). The proteins gE,
gI, and Us9 are all universally conserved in known neurotro-
pic 
 
 
 
-herpesvirus genomes. gE and gI are type I transmem-
brane proteins that typically form a heterodimer, whereas
Us9 is a type II tail-anchored membrane protein. Several
groups discovered that 
 
 
 
-herpesvirus gE, gI, or Us9 mutants
were able to replicate in primary neurons but were incapable
of spreading to secondary postsynaptic neurons (Card et al.,
1991, 1992; Kimman et al., 1992; Whealy et al., 1993;
Dingwell et al., 1995; Babic et al., 1996; Brideau et al.,
2000a,b). For example, after infection of the rat eye wild-
type PRV replicates in retinal neurons and spreads via the
optic nerve to secondary neurons in all visual nuclei in the
central nervous system (for review see Enquist et al., 1994).
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By contrast, gE, gI, or Us9-null mutants replicate well in ret-
inal neurons but do not spread to second-order neurons in
the superior colliculus in the midbrain (Whealy et al., 1993;
Husak et al., 2000; unpublished data). This defect is signifi-
cant, since 
 
 
 
90% of the retinal ganglion cells in the rat ret-
ina are in synaptic contact with neurons in the superior col-
liculus (Linden and Perry, 1983). Similar defects in the
spread of gE and gI mutant viruses from presynaptic to
postsynaptic neurons (often called anterograde spread) have
also been reported after nasal infection of swine (the natural
host of PRV) (Kritas et al., 1994a,b; Mulder et al., 1994,
1996). Although PRV gE, gI, and Us9 proteins are required
for efficient spread from presynaptic to postsynaptic neurons
through most neural circuits tested, these three proteins are
not required for spread from postsynaptic to presynaptic
neurons (often called retrograde spread) (Whealy et al.,
1993; Yang et al., 1999; Brideau et al., 2000a,b).
All available evidence suggests that the defect in antero-
grade transsynaptic spread exhibited by gE, gI, and Us9 mu-
tants occurs within the primary presynaptic infected neuron
(Husak et al., 2000). One hypothesis is that in gE, gI, or
Us9 mutant infections virions assembled in the cell body fail
to be transported into axons. An alternative suggestion is
that in mutant infections assembled virions enter axons but
can not be released from axon terminals. In this report, we
tested these hypotheses by examining the localization of vir-
ion structural proteins after wild-type or mutant infection of
cultured neurons. If the first hypothesis is true, virion struc-
tural proteins should not be found in axons after mutant in-
fections. If the second hypothesis is true, structural proteins
should be found in axons for both mutant and wild-type in-
fections. Our work revealed that neither hypothesis is cor-
rect and suggested a unique function for the Us9 protein.
Although the presence or absence of gE had no obvious ef-
fect on localization of virion structural proteins to axons of
infected neurons, after Us9-null mutant infections only a
subset of the viral structural proteins had entered axons. Sur-
prisingly, capsid and tegument proteins but not viral mem-
brane proteins were detected in axons.
 
We have previously used alanine substitution mutagenesis
to define Us9 residues essential for in vivo
 
 
 
anterograde
spread of PRV in the rat visual system (Brideau et al.,
2000b). This work indicated that two adjacent tyrosines
(Y49Y50) in an acidic motif (residues 46–56) were abso-
lutely essential for Us9 function (Fig. 1). In addition, we
found that two serines (S51S53) in the acidic domain were
phosphorylated, and alanine substitutions of these residues
affected the rate of Us9-dependent in vivo anterograde
spread. Finally, alanine substitution mutagenesis of two ad-
jacent leucine residues (L30L31) that function as an en-
docytosis motif (Brideau et al., 2000b) are dispensable for
anterograde spread in vivo. We infected cultured PNS neu-
rons with these mutant viruses to determine if the Us9-depen-
dent localization of viral membrane proteins correlated with
their ability to promote anterograde spread of infection in
vivo. We found that tyrosines 48 and 50 but not serines 51
and 53 were absolutely required for Us9-mediated mem-
brane protein localization in axons. Leucines 30 and 31
were completely dispensable for the axonal localization of
viral membrane proteins just as they are for anterograde
spread in vivo.
These results provide new insight into the process of virion
assembly and exit from neurons that leads to directional
spread of herpesviruses in the nervous system. We suggest that
a single viral protein (Us9) is responsible for the localization
of most if not all viral membrane proteins to the axon. If
membrane proteins are not localized to axons and transported
to axon terminals, viral infection cannot spread to synaptically
connected neurons. An important finding was that Us9 is not
required for localization of the capsid or tegument proteins to
the axon. An interpretation of our observations is that mature
virions are not assembled in the cell body and subsequently
transported in axons to the axon terminal. Rather, compo-
nents of mature virions are transported separately in axons to
terminals where infection of postsynaptic cells occurs.
Figure 1.  (A) The amino acid sequence of PRV Us9. Amino acids 
that have been substituted with alanine are bolded. The acidic 
region of Us9 is underlined with a solid line, and the predicted 
transmembrane domain is underlined with a dashed line. (B) The 
PRV Us9 missense mutants and their amino acid changes.
Figure 2. The axonal localization of the essential viral membrane 
protein gB requires Us9 but not gE. Less than 10% of the neurons in 
a culture were infected for 12 h with the wild-type (A and D), the 
gE-null mutant (B and E), or the Us9-null mutant (C and F) and then 
were fixed and permeabilized. Infected neurons were labeled with 
antibodies that recognize gB. A–C have image planes at the level of 
the cell bodies, whereas D–F have image planes at the substrate so 
that axons can be visualized. Arrows point to axons of infected neu-
rons, and N indicates the nucleus of infected neurons. Bar, 25  m. 
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Results
 
Determining the subcellular distribution of gB, an 
essential virion envelope protein in infected superior 
cervical ganglia neurons
 
Predictions from previous work were that gE and Us9 mu-
tants would be defective either in the transport of intracellu-
lar virions into axons or that mutant virions could not exit
from axon terminals (Husak et al., 2000). Accordingly, we
determined the localization of viral structural components in
neurons infected with wild-type or mutant viruses. Initially,
we examined the subcellular distribution of the viral glyco-
protein gB in neurons that were infected with wild-type, gE-
null, and Us9-null viruses. gB is an abundant viral mem-
brane protein that is required for virus entry and cell-to-cell
spread in all cells (Rauh and Mettenleiter, 1991). The kinet-
ics of expression and the cellular localization of gB were in-
distinguishable in the cell body of neurons infected with all
three viruses (Fig. 2 A compared with C). In neurons in-
fected with the wild-type and gE-null mutants, puncta of gB
immunoreactivity appeared in the axons at 
 
 
 
11 h after in-
fection (unpublished data). At 16 h after infection, gB
puncta could be found throughout the extent of axons of
neurons infected with either virus (Fig. 2, D and E, respec-
tively). However, in Us9-null infections very little gB could
be detected in the axons of infected neurons even at the lat-
est times after infection (Fig. 2 F). Occasionally, puncta of
gB immunoreactivity appeared in axons after Us9-null mu-
tant infection but only in the proximal portion of the axon.
These experiments provided the first direct evidence that
Us9 and gE may have different functions in infected neu-
rons leading to transsynaptic spread.
 
Us9 is required for axonal localization of two other 
viral membrane proteins
 
We next determined whether gC and gE, two abundant but
nonessential virion membrane proteins, localize to axons in
the absence of Us9 (Fig. 3). The results were similar to those
for gB described above: the amount of gC and gE and the dis-
tance the membrane proteins had traveled in the axon were
dramatically reduced during Us9-null mutant infections com-
pared with wild-type infections. Thus, three diverse virion
membrane proteins (gB, gC, and gE) required Us9 protein to
localize to and fill axons, even though no obvious defect in the
expression or localization of these glycoproteins within the cell
body was apparent by confocal microscopy.
 
Viral membrane proteins traffic through the secretory 
system during Us9-null infections
 
The absence of viral membrane proteins in axons during
Us9-null infections may reflect aberrant trafficking of vi-
Figure 3. The axonal localization of viral membrane 
proteins requires Us9. (A) Neurons were infected with 
the wild-type (a, b, and c) and the Us9-null virus 
PRV160 (d, e, and f) such that every neuron was 
infected for 16 h and then were fixed and permeabi-
lized. Infected neurons were labeled with antibodies 
that recognize gB (a and d), gC (b and e), and gE (c 
and f). Arrows point to axons that are labeled with 
viral membrane proteins in the wild-type infections. 
(B) The same experiment as above but at lower magni-
fication. Bars: (A) 25  m; (B) 150  m. 
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ral membrane proteins through the secretory system. Ac-
cordingly, we examined the kinetics of cell surface expres-
sion of a viral membrane protein during infection. If Us9-null
infections lead to retention of viral membrane proteins in
the secretory system, viral membrane proteins should not
be found on the surface of the infected cell. Neurons were
infected with the wild-type or the Us9-null virus for vary-
ing lengths of time, and the cell surface localization of gE
was examined. gE appeared on the neuronal surface after
infection with either virus (Fig. 4). The kinetics of surface
expression were similar for both viruses: detectable levels
of gE appeared 
 
 
 
7 h after infection (during experiments
where all neurons in a culture were infected). Despite sim-
ilar kinetics, gE initially surfaced on the axons of neurons
infected with the wild-type virus, but little to no gE was
detected on the surface of axons infected with the Us9-null
virus (unpublished data). By 9 h after infection, markedly
different surface-staining patterns were evident: gE covered
the surface of neurons during the wild-type infection, both
on the cell body and the axon (Fig. 4 A, a and b). During
Us9-null infections, little to no detectable staining appeared
on the axons (Fig. 4 A, c and d), despite significant staining
on the surface of the cell body. These results demonstrate
that gE is able to traffic through the secretory system to the
cell body surface during Us9-null mutant infections yet is not
targeted to the axon.
 
Targeting of cellular proteins is not disrupted during 
Us9-null infections
 
We examined the possibility that axonal targeting of cellular
proteins was disrupted during Us9-null mutant infections.
We first assessed the steady-state localization of the synaptic
vesicle marker SV2. Neurons were infected with the wild-
type, Us9-null, or were mock infected for 16 h and then
were fixed. Antibodies that recognized SV2 were used in in-
direct immunofluorescence experiments, and the levels of
staining were compared. SV2 staining appeared along the
length of the axon in the control sample (Fig. 4 B, a). No
notable difference in staining was found for either the wild-
Figure 4. Analysis of the neuronal secretory system 
during PRV infection. (A) Cell surface gE during wild-type 
or Us9-null infections. Neurons were infected such that 
every neuron was infected for 9 h with the wild-type (a 
and b) or Us9-null virus (c and d). Antibodies that recog-
nize gE were placed directly in the culture medium for 
5 min, and then unbound antibodies were removed and 
the infected neurons were fixed. (B) The steady-state 
localization of the synaptic vesicle marker SV2. Neurons 
were mock infected (a) or infected with the wild-type 
virus (b) or the Us9-null virus (c) such that every neuron 
was infected for 16 h, and then the neurons were fixed 
and permeabilized. An antibody that recognizes SV2 was 
then used in indirect immunofluorescence experiments. 
(C) The subcellular localization of a cellular protein (Ng-
CAM) expressed during PRV infection. A replication-
defective virus expressing the cellular protein NgCAM 
was used to infect cultured neurons. After 1 h, the 
medium was removed, and cultures were mock infected 
(a–c) or infected with the wild-type (d–f) or Us9-null virus 
(g–i). a–c show NgCAM localization in the absence of 
PRV infection. NgCAM appears on the surface of the cell 
body (a), in vesicles within the axon (b; note that this is an 
image of a large fasiculation, and therefore many axons 
are present within the bundle), and on the surface of the 
axon (c). NgCAM labeled the surface of neurons infected 
with wild-type virus (d) and Us9-null virus (g). The ex-
pression of gE during the wild-type (e) and Us9-null (h) 
infections demonstrates that they are infected with PRV. 
Merged images of the wild-type infection (f) and Us9-null 
infection (i) are shown with NgCAM in green and gE in red. 
Bars: (A, a and b, B, and C) 25  m; (A, c and d) 150  m. 
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type (Fig. 4 B, b) or the Us9-null infections (Fig. 4 B, c)
compared with the control.
Although this evidence is consistent with the hypothesis
that cellular proteins are targeted normally during Us9-null
mutant infections, it only examined the steady-state localiza-
tion of a cellular protein during infection. To assess the fate
of de novo–translated protein, we expressed a cellular pro-
tein that normally localizes to the axon (NgCAM) from a
replication-defective herpes simplex virus during PRV infec-
tions. The defective virus was first used to infect neurons,
and 1 h later either the wild-type or Us9-null virus was used
to superinfect cultured neurons. Because NgCAM is a
chicken protein, only protein expressed from the defective
virus is detectable with an antibody against the chicken pro-
tein (unpublished data). After 16 h of PRV infection, anti-
bodies against NgCAM were used to determine targeting of
the cellular protein to the axon. Fig. 4 C shows the expres-
sion of NgCAM after 18 h of infection with the replication-
defective virus. Staining is found predominantly on the cell
surface (Fig. 4 C, a and c) but also in vesicles within the
axon (Fig. 4 C, b and c). The intensity of expression was
drastically reduced during infection with PRV, but many
neurons expressed NgCAM adequately. NgCAM was found
on the surface of axons and cell bodies of neurons infected
with either wild-type (Fig. 4 C, d) or Us9-null mutant (Fig.
4 C, g). Taken together, these two experiments indicate that
axonal targeting of cellular proteins is not markedly dis-
rupted during infection with either the wild-type or the
Us9-null virus.
 
Critical domains defined for Us9 function in vivo are 
also required for localization of viral membrane 
proteins into axons
 
Brideau et al. (2000b) used alanine substitution mutagenesis
to define residues of Us9 required to promote anterograde
viral spread in the rat visual system (see Fig. 1 for the details
of these mutant viruses). These Us9 mutants (PRV 166,
172, and 173) differ
 
 
 
in the rate and extent of anterograde
spread in vivo. We infected cultured superior cervical gan-
glia (SCG) neurons with these viruses to determine if the ax-
onal localization of viral membrane proteins correlated with
anterograde spread in vivo
 
.
 
 PRV166 (L30L31 to AA)
spreads through the rat visual system like a wild-type virus
(Brideau et al., 2000b). Fig. 4, A–C, shows the results of
SCG infection with PRV166. All viral membrane proteins
examined (Fig. 5 A, gB; B, gC; and C, gE) localized to the
axons of infected neurons. These infections were similar to
the wild-type infections (Fig. 5, A–C, compared with Fig. 3
B, a–c). PRV173 (S51S53 to AA) is defective in rate but
ultimately approximates wild-type extent of anterograde
spread of infection in the rat visual system (Brideau et al.,
2000b). Infection of cultured neurons with PRV173 led to
an intermediate phenotype: all viral membrane proteins ex-
amined did localize to the axon (Fig. 5, G–I), but the extent
was reduced compared with the wild-type infection (Fig. 5,
G–I, compared with A–C). PRV172 (Y49Y50 to AA) has
the Us9-null phenotype (restricted anterograde spread) after
infection of the rat visual system (Brideau et al., 2000b). In-
fections of cultured neurons with this mutant were identical
to Us9-null virus infections; viral membrane proteins were
not found in axons, and only scattered vesicles were found
near the cell body (Fig. 5, D–F). These data demonstrate
that Us9-mediated membrane protein localization in axons
correlates well with the anterograde spread of infection in
the rat visual system.
Figure 5. Axonal localization of viral membrane proteins pro-
moted by Us9 missense mutants correlates with degree of antero-
grade spread in the rodent nervous system. Neurons were infected 
with PRV166 (L30L31 to AA) (A–C), PRV 172 (Y49Y50 to AA) (D–F), 
and PRV173 (S51S53 to AA) (G–I) such that every neuron was
infected for 16 h and then were fixed and permeabilized. See legend 
to Fig. I for a more detailed description of the Us9 mutant viruses. 
Infected neurons were labeled with antibodies that recognize gB (A, 
D, and G), gC (B, E, and H), and gE (C, F, and I). Bar, 150  m.
Figure 6. Colocalization of Us9 with other viral membrane pro-
teins within the axon. Neurons were infected with the wild-type 
virus such that every neuron was infected for 6 h, and then antibodies 
to Us9 (A, D, and G) and gB (B), gC (E), or gE (H) were added. The 
merged images are shown in C, F, and I with Us9 in green and the 
corresponding membrane protein in red. Bar, 10  m. 
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Us9 is not found on all vesicles within the axon
 
We examined the colocalization of Us9 and other viral
membrane proteins during wild-type infections. Us9 was
observed on vesicles close to the cell body of an infected neu-
ron (Fig. 6, A–C, gB; D–F, gC; and G–I, gE) but often did
not colocalize with viral membrane proteins containing vesi-
cles in the distal axon.
 
Us9 is not required for tegument protein localization
 
One hypothesis consistent with the results presented so far is
that Us9 but not gE protein is required to transport mature
(fully assembled) virions into axons of infected neurons. If
true, we predicted that other nonmembrane structural com-
ponents of the virus (that is, the capsid and the tegument)
would also require Us9 for localization in axons. To test this
prediction, we followed the localization of these virion com-
ponents over time in cultured neurons infected with wild-
type or Us9-null mutants.
We first focused on the localization of tegument proteins
in infected neurons. The tegument is the collection of pro-
teins just below the virus envelope and outside the capsid of
a herpes virion (Roizman and Furlong, 1974). Early in the
infection for the wild-type and Us9 mutants (
 
 
 
4–8 h after
infection), the tegument proteins VP22 and UL25 localized
most strongly to the nucleus but also were observed
throughout the cell body (unpublished data). Tegument
proteins could not be detected in axons during these early
stages of the infection. However, 
 
 
 
8 h after infection im-
munoreactivity for tegument proteins in the nucleus de-
creased with a concomitant increase in antibody staining of
infected axons during wild-type and Us9-null infections
(Fig. 7). Both VP22 and UL25 also localized to axons dur-
ing infections with Us9 missense mutants PRV 166, 172,
and 173 (unpublished data). We conclude that Us9 is not
required to localize the tegument proteins VP22 and UL25
to axons. Thus, the original hypothesis that Us9 is required
for localization of fully assembled virions to the axon is not
likely to be correct.
 
Us9 is not required for localization of capsid proteins 
to axons
 
The PRV capsid is an icosahedral structure that contains and
delivers the viral genome to the nucleus of an infected cell.
Early in the infection (
 
 
 
4–8 h after infection), an antibody
to the major capsid protein, VP5, stained the nucleus in-
tensely with weaker staining of the cytoplasm. This observa-
tion is consistent with the initial synthesis of VP5 in the cy-
toplasm and subsequent transport to the nucleus where it
assembles into capsids. Despite the significant localization of
VP5 in the nucleus and cell body, VP5 was not detected in
axons at this time (unpublished data). Approximately 8 h af-
ter infection, VP5 immunoreactivity was detected in the ax-
Figure 7. The axonal localization of the tegument proteins UL25 
and VP22 does not require Us9. Less than 10% of the neurons in 
the cultures were infected for 8 h with the wild-type (A) or the Us9-
null virus (C) and then were fixed and permeabilized. Antibodies 
that recognize UL25 (A and C) revealed the subcellular localization 
of this tegument protein in infected neurons. In a second series of 
experiments,  10% of the neurons in the cultures were infected for 
12 h with the wild-type (B) or the Us9-null virus (D) and then were 
fixed and permeabilized. The neurons were labeled with antibodies 
that recognize VP22 (B and D). Bar, 25  m.
Figure 8. The axonal localization of two capsid proteins does not 
require Us9. (A) Less than 10% of the neurons were infected for 12 h 
with the wild-type (a) or the Us9-null virus (b) and then were fixed 
and permeabilized. An antibody that recognizes the major capsid 
protein VP5 was used to label capsids in the infected neurons. (B) 
Viruses that express a GFP capsid fusion (GFP–VP26) from the wild-
type and Us9-null viral genomes were used to infect all neurons in 
the culture for 17 h and then were fixed and permeabilized. Anti-
bodies that recognize GFP-labeled capsids in the infected neurons. 
gE localization in the same fields is shown (c compared with d) and 
required Us9 to localize to axons. Bars: (A) 25  m; (B) 150  m. 
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ons of neurons infected with the wild-type and Us9 mutants
(Fig. 8 A, a and b). Wild-type levels of VP5 immunoreactiv-
ity was also found in axons of neurons infected with the Us9
missense mutants (unpublished data).
To confirm these findings, we constructed viruses that ex-
press green fluorescent protein (GFP) fused to another
capsid protein, VP26, in both wild-type and Us9-null virus
genomes. The capsids produced by these viruses are pre-
dicted to contain 900 copies of the GFP–VP26 fusion pro-
tein (Desai and Person, 1998; Smith et al., 2001). After in-
fection, neurons were fixed, and antibodies recognizing GFP
revealed the subcellular localization of VP26 and assembled
capsids. Again, we observed strong immunoreactivity in the
nucleus and a weaker signal throughout the cell body at early
times after infection. No GFP–VP26 was detected in the ax-
ons at these times (unpublished data). However, 
 
 
 
8 h after
infection immunoreactivity in the nucleus decreased, and
GFP–VP26 was found in the axons of neurons in the pres-
ence or absence of Us9. Fig. 6 B shows an experiment 17 h
after infection. GFP–VP26, presumably in assembled capsids,
localized to the cell body and axons of infected neurons for
the wild-type (Fig. 8 B, a) and Us9-null virus (Fig. 8 B, b).
As a control, we also examined simultaneously the localiza-
tion of membrane protein gE in these infections. As de-
scribed previously (Fig. 3), the axonal localization of gE re-
quires expression of Us9 (Fig. 8 B, c). In Us9-null mutant
infections, gE protein is confined mainly to the cell body
and is not found in axons (Fig. 8 B, d). By contrast, capsids
in the same infected cell, as deduced by GFP–VP26 stain-
ing, are found abundantly in axons in the presence or ab-
sence of Us9. Evidence that GFP–VP26 in axons is in as-
sembled capsids is described in Smith et al. (2001). These
experiments demonstrate that Us9 is required for axonal lo-
calization of viral membrane proteins but not capsids. Taken
together with data from the previous section, the results are
not consistent with the hypothesis that enveloped virions are
transported in axons.
 
Us9 is not involved in attachment, entry, or replication 
of PRV in SCG neurons
 
Us9-null mutants grow normally with no obvious defects
in attachment, entry, or replication in nonneuronal cells
(Brideau et al., 2000a). We observed that the Us9-null mu-
tant produced infectious virus at essentially the same rate
and to the same extent as wild-type virus in SCG neurons
(Fig. 9). Wild-type and Us9-null mutant viruses produced
relatively few infectious particles per neuron compared with
infection of nonneuronal cell lines such as PK15 cells. The
quantity of infectious virus released into the medium was
also low compared with nonneuronal cell lines. We note
that measurement of released virus is likely to be an underes-
timate as virus can bind avidly to the poly-lysine substrate
required for neuronal growth (unpublished data). Since
there are no differences in rate and extent of infectious virus
production among wild-type and Us9-null viruses, we con-
clude that Us9 does not affect viral attachment, entry, or
replication in SCG neurons during the duration of our ex-
periments. Therefore, the Us9-null phenotype is not due to
a replication defect.
 
Discussion
 
Directional spread of 
 
 
 
-herpesviruses into and out of the
PNS is a fundamental aspect of the viral life cycle. Upon pri-
mary infection of a natural host, virus travels from the pe-
ripheral epithelia to neuronal cell bodies of the PNS where it
usually establishes a latent infection. During reactivation,
the virus travels back to the periphery most likely in the
same neuron that had been infected some time before.
Movement of virion components to and from the cell body
of PNS neurons requires that viral proteins enter axons and
move substantial distances (Tomishima et al., 2001). Be-
cause access to the axon is restricted to a subset of neuronal
proteins, typically those involved in synapse formation and
function, it is likely that 
 
 
 
-herpesviruses have evolved mech-
anisms to interact with the axonal targeting and transport
machinery to ensure the transport of viral proteins into ax-
ons. We have demonstrated previously that Us9 is involved
in spread of virus from presynaptic to postsynaptic neurons
(Brideau et al., 2000a). Here, we provide a simple explana-
tion of this phenotype and demonstrate that Us9 is required
for the localization of most if not all viral membrane pro-
teins to the axon of infected neurons.
We were surprised to find that Us9 was not required to lo-
calize nonmembrane structural components of the virion
(for example, capsid and tegument proteins) to the axon.
This finding has important implications for herpesvirus as-
sembly and addresses a long-standing problem of how and
where the large and complex herpes virion is assembled in
infected PNS neurons. A widely held idea is that completely
assembled virions accumulate in the cell body and these na-
scent enveloped virions are transported in vesicles out of the
cell body into axons. Then, by microtubule-based motors
the vesicles carry the enveloped virions to the axon terminals
where they exit to infect the postsynaptic cell (Lycke et al.,
1984, 1988; Card et al., 1993; Kritas et al., 1995). In an-
other model first suggested by Penfold et al.
 
 
 
(1994) for
 
 
 
her-
pes simplex virus type 1, complete virions are not assembled
Figure 9. Us9 is not involved in viral attachment, entry, or repli-
cation in SCG neurons. Neurons were infected with the wild-type 
and the Us9-null virus such that every neuron was infected, and the 
amount of infectious virus (plaque forming units) produced at 1, 8, 
16, and 24 h after infection was determined. Each sample was 
performed in triplicate for both viruses, and only the data for the 
cell-associated virus is shown in the graph. 
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in the cell body but rather are assembled at or near the axon
terminal. These workers observed capsids in axons separate
from envelope proteins and never observed fully assembled
enveloped virions in axons of cultured human PNS neurons.
Penfold et al.
 
 
 
(1994) proposed that capsids destined for axon
terminals were not enveloped in the cell body but rather ac-
quired their envelope at or near the axon terminal such that
mature enveloped virions are released into the cleft between
neuron and epithelial cell. Our data are consistent with this
proposal. Moreover, we extend this model and suggest that
Us9 protein is required for axonal localization of virion en-
velope subassemblies but not tegument or capsid proteins.
We and others have found that the 
 
 
 
-herpesvirus genes
gE, gI, and Us9 are necessary for the anterograde spread of
infection in vivo
 
 
 
(Card et al., 1991, 1992; Kimman et al.,
1992; Whealy et al., 1993; Dingwell et al
 
.
 
, 1995; Babic et
al., 1996; Brideau et al., 2000a,b). One limitation of these
in vivo
 
 
 
experiments is the technical difficulty of examining
the cell biology of the infection. These previous experiments
have only looked at the replication of virus within first- or
second-order neurons. Consequently, it was not possible to
determine why the second-order neurons were not infected.
Here, we report that Us9 is responsible for localizing viral
membrane proteins to the axons of infected neurons, yet the
gE and gI proteins are not needed for this function. One
idea is that gE and gI accumulate at nerve terminals to pro-
mote the spread of infection from pre- to postsynaptic neu-
rons (Dingwell et al., 1995; Brideau et al., 2000a; Tirabassi
and Enquist, 2000).
The mechanism by which Us9 enables viral envelope pro-
teins to enter axons is under study. We tested three ideas ini-
tially. First, does Us9 “open” the axon to any membrane
protein, or does it discriminate among host and viral pro-
teins? To test this idea, we determined the localization of
well-known somatodendritic and axonal marker proteins
during infection and found that even late in the infection
(for example, 20 h) all marker proteins remained in their
proper compartments (unpublished data). Second, in the
absence of Us9 are all membrane proteins, including host
membrane proteins, blocked from entering axons in infected
cells? We performed two sets of experiments to address this
question. The first experiments examined the steady-state lo-
calization of a synaptic vesicle protein in uninfected cultures
and during wild-type or Us9-null mutant infections. No dif-
ference could be found between the uninfected and the
wild-type or Us9-null infections. We also demonstrated that
an axonal protein (NgCAM) translated during PRV infec-
tion was capable of trafficking into axons infected with ei-
ther the wild-type or the Us9-null virus. Finally, we tested
the idea that viral membrane proteins were unable to
progress through the secretory system in Us9-null infections.
We found that gE reaches the cell surface during Us9-null
infections with kinetics that are similar (if not identical) to
wild-type infections. Together, these data argue that the
secretory pathway is functional in Us9-null infections, and
the trafficking of cellular proteins into the axon is normal in
Us9-null infections. It appears that Us9 specifically pro-
motes the axonal delivery of viral membrane proteins.
Brideau et al
 
. 
 
(2000b) identified L30L31 and an acidic
domain (amino acids 46–56) as important residues for re-
trieval and TGN localization of Us9 from the plasma mem-
brane in nonneuronal cells. In addition, these authors found
that amino acids Y49Y50 in the acidic motif were essential
for Us9 to promote transneuronal spread of infection. By
contrast, the phosphorylated S51S53 residues affected rate
of viral spread, whereas the dileucine motif had no role in vi-
ral spread in the rat visual system (Brideau et al., 2000b).
Experiments in this report extend our understanding of
these phenotypes. Infection by PRV172 (Y49Y50 to AA),
which has a Us9-null phenotype in vivo, also had a null phe-
notype after infection of cultured neurons: all viral mem-
brane proteins tested were markedly reduced in axons.
PRV173, an Us9 alanine substitution mutant with a partial
loss-of-function phenotype in anterograde spread in animals
also had an intermediate phenotype in cultured neurons. Fi-
nally, PRV166, which has no phenotype in vivo, is indistin-
guishable from wild-type infection of cultured neurons. We
can now surmise for the first time why Us9-null mutants are
defective in directional transneuronal spread: membrane
proteins such as gB that are absolutely required for transneu-
ronal spread (Babic et al., 1993) do not enter axons in the
absence of Us9.
How does Us9 promote localization of viral membrane
proteins to axons? Us9 has no obvious homology to any pro-
tein or nucleic acid sequences in GenBank that might pro-
vide insight into how it functions. However, the motifs
identified by alanine substitution mutations discussed above
suggest that Us9 may participate in recruiting cytoplasmic
coat proteins, allowing the formation of vesicles destined for
different subcellular locations (for review see Kirchhausen et
al., 1997; Schmid, 1997; Lewin and Mellman, 1998). The
deletion of a 10 amino acid highly conserved acidic motif
(residues 46–56) region of Us9 blocks retrieval of Us9 from
the plasma membrane to a compartment in or near the
TGN, implicating this region in the recruitment of the
adaptor protein AP-2 necessary for clathrin-dependent en-
docytosis. This deletion mutation also removes two serines
that are likely to be phosphorylated (Brideau et al., 2000b).
The cell adhesion molecule L1, the endoprotease furin, the
mannose-6-phosphate receptor, and many other viral pro-
teins have a YXX
 
 
 
 motif near an acidic cluster that contains
serine residues capable of being phosphorylated by casein ki-
nase I and II. The trafficking of these proteins is regulated
by casein kinase II phosphorylation and the tyrosine-based
sorting signal (Trowbridge et al., 1993; Jones et al., 1995;
Takahashi et al., 1995; Alconada et al., 1996; Wong et al.,
1996; Breuer et al., 1997).
The Y49Y50 motif and acidic domain are conserved
throughout the known Us9 homologues in all 
 
 
 
-herpesvi-
ruses (Brideau et al., 1999). This YY motif is different from
the YXX
 
 
 
 motif that classically has been shown to mediate
interactions with adaptor proteins (Bonifacino and Dell’An-
gelica, 1999). Nevertheless, given the phenotypes of the YY
to AA mutants we suggest that the two tyrosines critical for
Us9 function interact with particular cytoplasmic adaptor
proteins necessary for the movement of vesicles between
compartments of the cell. There is a precedent for herpesvi-
ruses usurping adaptor-mediated targeting during infection:
the PRV membrane protein gE has been shown to direct
vesicles containing virions to the basolateral domain of po- 
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larized epithelial cells, and this sorting is dependent on the
adaptor complex AP-1 (Johnson et al., 2001).
We propose a model (Fig. 10) where viral membrane pro-
teins achieve a steady-state localization in the trans-Golgi
network or a post-Golgi compartment in the cell body.
Once in this compartment, viral membrane proteins are se-
lectively incorporated into vesicles destined for the axon. In
the simplest case, the presence of Us9 in the compartment
recruits a neuron-specific adaptor complex that binds to Us9
via the dityrosine motif (for example, some forms of AP-3
are possible candidates) (Pevsner et al., 1994), leading to the
formation of transport vesicles carrying Us9 and other viral
membrane proteins “coated” with the axonal adaptors.
Therefore, in the absence of Us9 vesicles, containing viral
membrane proteins would not be directed to the axon. The
cytoplasmic tails of other viral membrane proteins could still
bind to other adaptor complexes, allowing vesiculation and
transport to the cell surface or movement to compartments
other than the axon. In this model, only one molecule in a
transport vesicle need carry the cis-acting axonal sorting sig-
nal. Such a “piggyback” model of axonal targeting of neu-
ronal proteins has been proposed recently (Roos and Kelly,
2000). Other proteins within the vesicle gain access to the
axon simply by being in the same vesicle as the protein with
the sorting signal. We propose that Us9 represents such an
axon-specific sorting molecule and that other viral mem-
brane proteins are merely “cargo.” However, our observation
that not all of the vesicles within the axon contain Us9 is
noteworthy. Perhaps only vesicles moving into the axon
contain Us9, whereas the non-Us9–containing vesicles en-
riched in the distal axon represent viral membrane proteins
that have accumulated within an organelle (for example, an
endosome). Alternatively, Us9 may function in the cell body
of the neuron to alter the trafficking patterns of viral mem-
brane proteins. We are in the process of testing these ideas.
In summary, we find that virion assembly is intimately as-
sociated with directional spread of infection between neu-
rons. It had been assumed that complete virus particles were
assembled in the cell body and then moved into axons for
long distance travel to axon terminals. Our results support
an alternative model proposed by Penfold et al. (1994),
whereby structural components of the virus are moved sepa-
rately into the axons of infected neurons for later assembly.
Our genetic data indicate that the loss of a single gene, Us9,
leads to a wholesale change in the subcellular localization in
PNS neurons of all viral membrane proteins examined yet
does not change the localization of capsid and tegument
proteins. Since viruses must subvert host processes during
their replication, understanding how Us9 changes the polar-
ity of viral membrane proteins during infection should re-
veal conserved neuronal proteins involved in axonal target-
ing and transport and may provide insight into the general
mechanism of directional axonal transport. Cell biologists
have long relied on selected viral proteins to facilitate an un-
derstanding of intracellular trafficking and polarized protein
delivery. 
 
 
 
-Herpesviruses have evolved mechanisms to para-
sitize and coexist with neurons of a broad range of hosts, and
they may offer new tools to probe the cellular and molecular
mechanisms of polarized protein traffic in neurons.
 
Materials and methods
 
Virus strains and cells
 
The Porcine kidney cell line PK15 and all viruses were grown and main-
tained as described previously (Whealy et al., 1993). The laboratory
strain of PRV used as the wildtype and parent for all virus constructions
was PRV-Becker (Card et al., 1990). The isogenic mutants PRV 160 (Us9-
null), PRV 166 (L30L31 to AA), PRV 172 (Y49Y50 to AA), and PRV 173
(S51S53 to AA) have been described (see Fig. 1 for amino acid sequence
of Us9 and location of the alanine substitution mutations) (Brideau et al.,
2000a,b). PRV 91 (gE-null) has been described (Whealy et al., 1993).
PRV 160R is a revertant of PRV 160 that restores all tested wild-type virus
phenotypes (Brideau et al., 2000a). In this study, PRV 160R and PRV-
Becker were also indistinguishable. PRV-GS443 was constructed by G.A.
Smith (Smith et al., 2001) and expresses a hybrid protein comprising the
GFP fused to the capsid protein VP26. PRV 368 carries both the Us9-null
mutation from PRV 160 and the 
 
GFP–UL35 
 
hybrid gene from PRV-
GS443 replacing the 
 
UL35
 
 gene. It was constructed by recombination
between PRV 160 and PRV-GS443. The replication-defective herpes sim-
plex virus vector that expresses the axonal chicken protein NgCAM was
a gift from G. Banker and has been described previously (Jareb and
Banker, 1998).
 
Antibodies
 
The polyclonal rabbit antiserum recognizing gE (Rb 501) and the poly-
clonal goat antisera recognizing gB (Ab284) and gC (Ab282) have been de-
scribed (Whealy et al., 1993; Tirabassi and Enquist, 2000). The mono-
clonal antibody IN-13 recognizing the major capsid protein VP5 was a gift
from H. Rziha (Federal Research Centre for Virus Diseases of Animals,
Figure 10. A model for Us9-dependent axonal sorting of viral 
membrane proteins. Us9 is depicted as a white rectangle, and other 
viral membrane proteins are black “lollipops.” The adaptor complex 
AP-1 is shown as a hexagon, and AP-3 is shown as a star. (A) The 
targeting of viral membrane proteins to the axon requires Us9. A 
tyrosine-based cytoplasmic sorting signal in Us9 interacts with 
AP-3, allowing the formation of axonal transport vesicles coated 
with this adaptor complex. Other viral membrane proteins are 
passive “cargo” that are targeted to the axon due to an association 
with Us9, not a cis-acting peptide sequence. The cytoplasmic tails 
of other viral membrane proteins can still interact with other adap-
tor complexes in wild-type infections, allowing transport vesicles to 
traffic to other regions of the neuron in addition to the axon.
(B) Without Us9, no axonal-sorting signal is present on the cytoplas-
mic tails of viral membrane proteins. Vesicles still form but are no 
longer targeted to the axon. The cytoplasmic tails of other viral 
membrane proteins still interact with other adaptor complexes, 
allowing transport vesicles to traffic to other regions of the neuron. 
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Tubingen, Germany). The monoclonal antibody recognizing VP22 was a
gift from T. Mettenleiter (Federal Research Centre for Virus Diseases of An-
imals, Insel Riems, Germany). The polyclonal mouse antiserum recogniz-
ing the tegument protein UL25 was a gift from A. Flamand (Centre
National de la Recherche Scientifique, Gif-sur Yvette, France). The mono-
clonal antibody recognizing GFP was purchased from Molecular Probes.
The monoclonal antibody 8D9 recognizing the chick adhesion molecule
NgCAM was a gift from G. Banker (Oregon Health Sciences University,
Portland, OR)
 
Neuronal culture
 
Rat sympathetic neurons from the SCG of rat embryos (15–16 d gesta-
tion) were dissociated according to the methods of DiCicco-Bloom et al.
(1993). 35-mm plastic dishes (353001; Falcon) were coated with 100
 
 
 
g/ml poly-
 
D
 
-lysine (P-6407; Sigma-Aldrich) in tissue culture grade wa-
ter (W-3500; Sigma-Aldrich). Approximately 80,000 neurons per dish
were plated. Cultures were maintained in 50% Ham’s F-12 medium
(11765-054; GIBCO BRL) and 50% DME (11965-084; GIBCO BRL) sup-
plemented with 10 mg/ml BSA (A-2153; Sigma-Aldrich), 10 
 
 
 
g/ml insu-
lin (I-6634; Sigma-Aldrich), 100 
 
 
 
g/ml transferrin (616397; Calbiochem),
100 
 
 
 
M putrescine (P-7505; Sigma-Aldrich), 20 nM progesterone (P-
6149; Sigma-Aldrich), 30 nM selenium (S-5261; Sigma-Aldrich), 2 mM
glutamine (15039-027; GIBCO BRL), 6 mg/ml glucose (4912; Mallinck-
rodt), 50 
 
 
 
g/ml penicillin and 50 
 
 
 
g/ml streptomycin (15140-122;
GIBCO BRL), and 100 ng/ml NGF 2.5S (13257-019; GIBCO BRL). Cul-
ture medium was replaced three times per week and was equilibrated for
 
 
 
1 h in a 37
 
 
 
C 5% CO
 
2
 
 incubator before use. Cytosine-
 
 
 
-
 
D
 
-arabino-
furanoside (C-6645; Sigma-Aldrich) was added to 2 
 
 
 
M from days 2–3
and 5–6 to eliminate dividing cells. Experimental protocols were ap-
proved by the Animal Welfare Committee at Princeton University and
were consistent with the regulations of the American Association for Ac-
credition of Laboratory Animal Care and those in the Animal Welfare Act
(public law 99-198).
 
Expression of cellular proteins during PRV infection
 
Neurons were cultured in 35-mm plastic dishes for at least 3 wk as de-
scribed above. 30 
 
 
 
l of replication-defective herpes simplex virus vectors
were added directly to the neuronal culture medium for 1 h (Jareb and
Banker, 1998). After this incubation, this medium was removed, and me-
dium containing PRV-Becker (wild-type) or PRV 160 (Us9-null virus) was
placed on the neurons at a concentration of virus that permits infection of
all neurons in a culture (see below). After 1 h, the PRV-containing medium
was removed, and the original medium containing the replication-defec-
tive virus was placed back on the neurons. 16 h after PRV infection, the
neurons were fixed, and NgCAM expressed from the viral vector was visu-
alized using an antibody that recognizes only the chicken protein (Ng-
CAM) and not the rat orthologue.
 
Indirect immunofluorescence microscopy
 
Neurons were cultured in 35-mm plastic dishes for 
 
 
 
3 wk as described
above. At this time, the axonal network was extensive. Two concentrations
of virus inoculum were used: a low multiplicity of infection such that
 
 
 
10% of the cells were infected and a high multiplicity of infection such
that almost all neurons were infected. We found that the majority of the in-
put virions bound directly to the tissue culture dish and never came into
contact with the cultured neurons (unpublished data). Therefore, precise
calculations of the multiplicity of infection are difficult. After 1 h, the inoc-
ulum was removed by aspiration and replaced with the original culture
medium that had been incubated at 37
 
 
 
C. At various times after infection,
neurons were rinsed with PBS, fixed with 3.2% paraformaldehyde, and
then rinsed three times with PBS. The neurons were permeabilized for 3
min in PBS containing 3% BSA and 0.5% saponin. In all subsequent ma-
nipulations, PBS containing 3% BSA and 0.5% saponin is included in the
solutions. Fixed cells were then incubated with the appropriate primary
antibody for 1 h in a humidified chamber at 37
 
 
 
C. The dishes were rinsed
three times with PBS/BSA/saponin and incubated with Alexa 488– or Alexa
568–conjugated secondary antibodies (Molecular Probes) for 1 h in a hu-
midified chamber at 37
 
 
 
C. Finally, the dishes were rinsed three times with
PBS/BSA/saponin and once with distilled water. A drop of Vectashield
mounting medium (H 1000; Vector Laboratories) was placed in the floor of
the dish, and then a coverslip was placed on the Vectashield and sealed
with nail polish.
Experiments examining the cell surface localization of proteins were
performed as follows: after infection, antibodies were diluted in a small
volume of neuron culture medium (600 
 
 
 
l per 35-mm dish), and this was
placed on the infected neurons for 5 min at 37
 
 
 
C, and then the neurons
were rinsed once with PBS and fixed for 10 min in 3.2% paraformalde-
hyde. After fixation, the neurons were rinsed with PBS three times and
were incubated in 3% BSA in PBS overnight. Secondary antibodies were
diluted in 3% BSA in PBS and were incubated with the fixed neurons for 1 h.
Finally, the neurons were processed as described above.
Low multiplicity infections were useful as the large number of unin-
fected neurons provided internal controls for nonspecific antibody bind-
ing. Low multiplicity infections also enabled us to locate and follow the
long axons from single infected cell bodies. High multiplicity infections
confirmed that phenotypes were uniform throughout all neurons in the
culture. Unless otherwise indicated, all times after infection are based on
low multiplicity infections.
Single optical sections were captured using a Nikon Optiphot-2 micro-
scope equipped with a Bio-Rad Laboratories MRC600 scan head. Images
were processed with Adobe Photoshop
 
®
 
 (version 4.0).
 
Determining polarity of cultured neurons: targeting and 
retention of control cytoskeletal components to cell bodies 
and axons
 
Many types of neurons can not sort their proteins to axonal or dendritic
compartments until at least 2 wk of growth in vitro (Caceres et al., 1986;
Goslin et al., 1990; Ledesma et al., 1999). Rat sympathetic neurons de-
rived from the SCG are reported to sort endogenous proteins to axonal and
somatodendritic compartments after 3 wk in vitro
 
 
 
(Bruckenstein and Hig-
gins, 1988). The polarity of cultured neurons used in this report was deter-
mined by analysis of three control proteins: (a) the axonal markers tau-1
(Boehringer) and SMI-31 (Sternberger-Meyer Immunochemicals), and (b)
the cell body/dendrite markers MAP2 (Boehringer) and SMI-32 (Stern-
berger-Meyer Immunochemicals). The antibody SMI-31 recognizes the
phosphoforms of the M and H neurofilament, whereas the antibody SMI-
32 reacts with the nonphosphoforms of the M and H neurofilament (Stern-
berger and Sternberger, 1983). Since neuronal cell bodies are raised as
much as 20  m from the floor of the tissue culture dish where the axons
grow, two different image planes are shown in Fig. 11, D–K: the top panels
(Fig. 11, D–G) show an image plane at the center of the cell bodies (above
the substratum), whereas the bottom panels (Fig. 11, H–K) have the image
plane at the substratum where the neurites can be visualized.
The axonal marker tau-1 was found in nearly all neurites examined in
the cultures. Faint immunoreactivity was found within cell bodies of neu-
Figure 11. Characterization of cultured SCG neurons. Phase–
contrast images of neurons after 3 h (A), 5 d (B), or 21 d (C) in 
culture. The establishment of cell polarity of SCG neurons after 21 d 
in culture is demonstrated in D–K. After fixing and permeabilizing, 
the neurons were labeled with antibodies that recognized the 
axonal markers tau-1 (D and H) and phospho-M and H neurofila-
ment (E and I) or the somatodendritic markers MAP2 (F and J) and 
nonphospho-M and H neurofilament (G and K). Two confocal 
images of each field are shown: D–G have image planes at the level 
of the cell bodies, whereas H–K show the same neuron at the level 
of the substratum so that axons can be visualized. Bar, 25  m. Us9 directs herpesviral membrane proteins to axon | Tomishima and Enquist 751
rons (Fig. 11 D), but most of the staining was confined to the neurites (Fig.
11 H). Similar neurite localization was seen with the second axonal
marker, SMI-31 (Fig. 11, E and I). The cell body/dendrite marker MAP2
(Fig. 11, F and J) localized mainly to the cell body. Some immunoreactivity
was also found in a proximal-to-distal gradient within the neurites with the
strongest immunoreactivity in the proximal axon. The same was true for
the second cell body/dendrite marker SMI-32 (Fig. 11, G and K). However,
the extent of proximal axon staining with SMI-32 was not as pronounced
as the MAP2 staining pattern. These data are consistent with previously
published studies on the polarity of this culture system (Peng et al., 1986;
Bruckenstein and Higgins, 1988).
Kinetics of infectious PRV production in SCG neurons
The embryonic ganglia from a pregnant rat were pooled and dissociated,
and the SCG neurons resulting from that preparation were plated into a 24-
well dish ( 2,500 neurons per well). We determined empirically that
250,000 plaque-forming units (as determined on PK15 cells) were required
in each well to infect all neurons in the culture. Added virus was incubated
with neurons for 1 h to facilitate attachment of virus to cells. The inoculum
was then removed and fresh medium added. The supernatant and neurons
were collected at 1, 8, 16, and 24 h after infection. Each time after infec-
tion was assayed in triplicate, and the quantitation of infectious virus in
each sample was determined on PK15 cells.
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